<DOC>
	<DOCNO>NCT01063803</DOCNO>
	<brief_summary>This open-label extension study allow subject complete either 3242K1-2000-WW 3242K1-2001-JA study receive additional 48 week ATN-103 treatment provide data long-term safety tolerability ATN-103 subject rheumatoid arthritis .</brief_summary>
	<brief_title>Study Evaluating Long-Term Safety Of ATN-103 In Subjects With Rheumatoid Arthritis</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<criteria>Subjects must complete study 3242K12000WW 3242K12001JA event , opinion investigator , would preclude entry participation study . Pregnant nursing woman . Any major illness/condition evidence unstable clinical condition ( eg , renal , hepatic , cardiovascular , hematological , gastrointestinal , endocrine , pulmonary , immunologic [ eg , Felty syndrome , human immunodeficiency virus ( HIV ) infection ] , infectious , neurological , cerebral psychiatric disease , evidence demyelinate disease ) , investigator 's judgment , substantially increase risk associate subject 's develop adverse event ( AE ) serious adverse event ( SAE ) study , preclude evaluation subject 's response .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>Open-label</keyword>
	<keyword>Long-term safety study ATN-103 RA</keyword>
</DOC>